Cigna Group
XMUN:CGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cigna Group
XMUN:CGN
|
US |
|
Infotel SA
PAR:INF
|
FR |
|
Amplitude Inc
NASDAQ:AMPL
|
US |
|
O
|
Osaka Gas Co Ltd
DUS:OSA
|
JP |
Cigna Group
Cigna Group, a recognized titan in the health services landscape, traces its origins to 1792 when it began as the Insurance Company of North America (INA). This rich history speaks volumes about its deep-rooted expertise and robust resilience in an ever-evolving industry. Today, Cigna operates as a global health services powerhouse, deriving its core revenues from an intricate blend of health insurance products and services targeted towards employers, individuals, and government entities. The company's ability to seamlessly fuse traditional insurance models with innovative health solutions highlights its commitment to improving patient outcomes. Cigna's operational model is anchored on its extensive provider network, supplemented by a suite of digital health tools aimed at enhancing customer engagement. This hybrid approach not only simplifies access to medical care but also reinforces its strategic focus on affordability and personalized health journeys for its clients. Financially, Cigna's success is a byproduct of its diversified revenue streams, encompassing global health care, international markets, and supplemental health benefits. At its core, Cigna makes money through premium collections, investment income, and administrative fees from managing prescription drug plans and health services. With the acquisition of Express Scripts in 2018, Cigna prominently positioned itself in the pharmacy benefits management sector, adding another lucrative revenue channel. This strategic maneuver has fostered vertical integration within the company, aligning its pharmacy services with its insurance offerings to manage costs more effectively. Through a relentless pursuit of operational efficiency and strategic expansion, Cigna continues to leverage its scale and diversified offerings, remaining a key player in delivering accessible and cost-effective health care solutions worldwide.
Cigna Group, a recognized titan in the health services landscape, traces its origins to 1792 when it began as the Insurance Company of North America (INA). This rich history speaks volumes about its deep-rooted expertise and robust resilience in an ever-evolving industry. Today, Cigna operates as a global health services powerhouse, deriving its core revenues from an intricate blend of health insurance products and services targeted towards employers, individuals, and government entities. The company's ability to seamlessly fuse traditional insurance models with innovative health solutions highlights its commitment to improving patient outcomes. Cigna's operational model is anchored on its extensive provider network, supplemented by a suite of digital health tools aimed at enhancing customer engagement. This hybrid approach not only simplifies access to medical care but also reinforces its strategic focus on affordability and personalized health journeys for its clients.
Financially, Cigna's success is a byproduct of its diversified revenue streams, encompassing global health care, international markets, and supplemental health benefits. At its core, Cigna makes money through premium collections, investment income, and administrative fees from managing prescription drug plans and health services. With the acquisition of Express Scripts in 2018, Cigna prominently positioned itself in the pharmacy benefits management sector, adding another lucrative revenue channel. This strategic maneuver has fostered vertical integration within the company, aligning its pharmacy services with its insurance offerings to manage costs more effectively. Through a relentless pursuit of operational efficiency and strategic expansion, Cigna continues to leverage its scale and diversified offerings, remaining a key player in delivering accessible and cost-effective health care solutions worldwide.
Beat and raise: The Cigna Group said second-quarter results were strong, with both Evernorth and Cigna Healthcare ahead of expectations, and raised full-year 2026 adjusted EPS guidance to at least $30.45.
Revenue and EPS: Quarterly revenue was $71.7 billion and adjusted EPS was $7.78, while adjusted after-tax earnings were $2.1 billion.
Specialty strength: Evernorth’s Specialty & Care Services business was a major driver, with pretax adjusted earnings up 22% year over year and faster-than-expected adoption of biosimilars and specialty generics.
PBM transition: The company said Pharmacy Benefit Services was affected by contract renewals and investments tied to the new rebate-free Signature model, but 2027 selling season momentum is strong and Signature is drawing early interest.
Healthcare trends: Cigna Healthcare posted pretax adjusted earnings growth of 17%, with a medical care ratio of 84.5% and cost trends described as high-single-digit but stable.
Capital and cash flow: Operating cash flow was in line with expectations, share repurchases totaled about $250 million, and the company still expects about $9 billion of operating free cash flow for the full year.